Meningococcal Vaccine Market Research Report 2021-2031
The Meningococcal Vaccine Market is expected to register a CAGR of 6.0% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Bivalent, Quadrivalent, Others). The report further presents analysis based on the Brand (Menactra, Menveo, Bexsero, Trumenba, Nimenrix, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Meningococcal Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Meningococcal Vaccine Market Segmentation
Type- Bivalent
- Quadrivalent
- Others
- Menactra
- Menveo
- Bexsero
- Trumenba
- Nimenrix
- Others
Strategic Insights
Meningococcal Vaccine Market Growth Drivers- Increased Meningococcal Cases Boost Vaccine Demand: High incidence in the meningococcal disease population worldwide is primarily driving the market for meningococcal vaccines. Outbreaks and increased infection rates among high-risk populations, particularly infants and adolescents, require vaccination by healthcare professionals, adding to the demand for effective vaccines.
- Government Vaccination Programs: Growing popularity of public health campaigns and government initiatives is one reason for the meningococcal vaccine market growth. Most of the nations have put into practice routine immunization of at-risk groups, hence its accessibility and availability in the health care facility are increased.
- Awareness Regarding Preventive Healthcare: An increase in the need for the meningococcal vaccine due to increased awareness of people concerning preventive health care measures is the driving force. The more the awareness regarding prevention, the higher the uptakes and proactive health practices, which will indirectly boost market growth.
- Combination Vaccines Development: New waves of conjugate vaccines are developed in terms of developing combination vaccines that offer protection against multiple strains of meningococcal bacteria. These vaccines offer a broader spectrum of immunity and thus are more handy as compared to the presently available single-strain vaccines. The benefits associated with these vaccines are hence making them highly popular among healthcare facilities and patients in general, thus creating a market growth opportunity.
- Focus on Greater Vaccine Efficacy: Continued research and development would continue to strengthen the efficacy and safety profiles of meningococcal vaccines. Continued improvements in formulations and delivery methods, through innovation and development, will enhance protection and public confidence in vaccination, thus driving further market expansion.
- Public-private Collaboration: More of public health agencies are now partnering with private vaccine manufacturers to enhance the delivery and access of vaccines, leading to increased vaccination rates and an increasing market for meningococcal vaccines.
- Increased awareness and education: Parents and youths who are raising their knowledge of meningococcal disease increase the number. Education campaigns stimulate demand for vaccination in regions where there is a high frequency of outbreaks or low vaccination rates.
- Increased penetration in emerging markets: Vaccination coverage is relatively low in various emerging markets, but the meningococcal disease rate is on the rise. Increased access and affordability of vaccines in the regions can promote extensive market penetration.
- Development of Combination Vaccines: Combination vaccines that would include protection against meningococcal, as well as other vaccines such as HPV or pneumococcal vaccines, will certainly make it easier to implement immunization schedules, and the appeal to providers and patients is strong enough to push upwards the rate of vaccination.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Meningococcal Vaccine Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Meningococcal Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The meningococcal vaccine market is estimated to grow with a CAGR of 6.0% from 2023 to 2031.
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
The meningococcal vaccine market majorly consists of players such as Pfizer Inc, Novartis AG, Sanofi among others
Development Of Combination Vaccines is likely to remain the key trend during the forecast period.
The market drivers include rising incidence of meningococcal disease and government initiatives and public health campaigns promoting meningococcal vaccination are driving the meningococcal vaccine market
North America dominated the meningococcal vaccine market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Meningococcal Vaccine Market - By Type
1.3.2 Meningococcal Vaccine Market - By Brand
1.3.3 Meningococcal Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MENINGOCOCCAL VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MENINGOCOCCAL VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MENINGOCOCCAL VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MENINGOCOCCAL VACCINE - GLOBAL MARKET OVERVIEW
6.2. MENINGOCOCCAL VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MENINGOCOCCAL VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIVALENT
7.3.1. Overview
7.3.2. Bivalent Market Forecast and Analysis
7.4. QUADRIVALENT
7.4.1. Overview
7.4.2. Quadrivalent Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. MENINGOCOCCAL VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - BRAND
8.1. OVERVIEW
8.2. BRAND MARKET FORECASTS AND ANALYSIS
8.3. MENACTRA
8.3.1. Overview
8.3.2. Menactra Market Forecast and Analysis
8.4. MENVEO
8.4.1. Overview
8.4.2. Menveo Market Forecast and Analysis
8.5. BEXSERO
8.5.1. Overview
8.5.2. Bexsero Market Forecast and Analysis
8.6. TRUMENBA
8.6.1. Overview
8.6.2. Trumenba Market Forecast and Analysis
8.7. NIMENRIX
8.7.1. Overview
8.7.2. Nimenrix Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. MENINGOCOCCAL VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Meningococcal Vaccine Market Overview
9.1.2 North America Meningococcal Vaccine Market Forecasts and Analysis
9.1.3 North America Meningococcal Vaccine Market Forecasts and Analysis - By Type
9.1.4 North America Meningococcal Vaccine Market Forecasts and Analysis - By Brand
9.1.5 North America Meningococcal Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Meningococcal Vaccine Market
9.1.5.1.1 United States Meningococcal Vaccine Market by Type
9.1.5.1.2 United States Meningococcal Vaccine Market by Brand
9.1.5.2 Canada Meningococcal Vaccine Market
9.1.5.2.1 Canada Meningococcal Vaccine Market by Type
9.1.5.2.2 Canada Meningococcal Vaccine Market by Brand
9.1.5.3 Mexico Meningococcal Vaccine Market
9.1.5.3.1 Mexico Meningococcal Vaccine Market by Type
9.1.5.3.2 Mexico Meningococcal Vaccine Market by Brand
9.2. EUROPE
9.2.1 Europe Meningococcal Vaccine Market Overview
9.2.2 Europe Meningococcal Vaccine Market Forecasts and Analysis
9.2.3 Europe Meningococcal Vaccine Market Forecasts and Analysis - By Type
9.2.4 Europe Meningococcal Vaccine Market Forecasts and Analysis - By Brand
9.2.5 Europe Meningococcal Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Meningococcal Vaccine Market
9.2.5.1.1 Germany Meningococcal Vaccine Market by Type
9.2.5.1.2 Germany Meningococcal Vaccine Market by Brand
9.2.5.2 France Meningococcal Vaccine Market
9.2.5.2.1 France Meningococcal Vaccine Market by Type
9.2.5.2.2 France Meningococcal Vaccine Market by Brand
9.2.5.3 Italy Meningococcal Vaccine Market
9.2.5.3.1 Italy Meningococcal Vaccine Market by Type
9.2.5.3.2 Italy Meningococcal Vaccine Market by Brand
9.2.5.4 Spain Meningococcal Vaccine Market
9.2.5.4.1 Spain Meningococcal Vaccine Market by Type
9.2.5.4.2 Spain Meningococcal Vaccine Market by Brand
9.2.5.5 United Kingdom Meningococcal Vaccine Market
9.2.5.5.1 United Kingdom Meningococcal Vaccine Market by Type
9.2.5.5.2 United Kingdom Meningococcal Vaccine Market by Brand
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Meningococcal Vaccine Market Overview
9.3.2 Asia-Pacific Meningococcal Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Meningococcal Vaccine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Meningococcal Vaccine Market Forecasts and Analysis - By Brand
9.3.5 Asia-Pacific Meningococcal Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Meningococcal Vaccine Market
9.3.5.1.1 Australia Meningococcal Vaccine Market by Type
9.3.5.1.2 Australia Meningococcal Vaccine Market by Brand
9.3.5.2 China Meningococcal Vaccine Market
9.3.5.2.1 China Meningococcal Vaccine Market by Type
9.3.5.2.2 China Meningococcal Vaccine Market by Brand
9.3.5.3 India Meningococcal Vaccine Market
9.3.5.3.1 India Meningococcal Vaccine Market by Type
9.3.5.3.2 India Meningococcal Vaccine Market by Brand
9.3.5.4 Japan Meningococcal Vaccine Market
9.3.5.4.1 Japan Meningococcal Vaccine Market by Type
9.3.5.4.2 Japan Meningococcal Vaccine Market by Brand
9.3.5.5 South Korea Meningococcal Vaccine Market
9.3.5.5.1 South Korea Meningococcal Vaccine Market by Type
9.3.5.5.2 South Korea Meningococcal Vaccine Market by Brand
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Meningococcal Vaccine Market Overview
9.4.2 Middle East and Africa Meningococcal Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Meningococcal Vaccine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Meningococcal Vaccine Market Forecasts and Analysis - By Brand
9.4.5 Middle East and Africa Meningococcal Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Meningococcal Vaccine Market
9.4.5.1.1 South Africa Meningococcal Vaccine Market by Type
9.4.5.1.2 South Africa Meningococcal Vaccine Market by Brand
9.4.5.2 Saudi Arabia Meningococcal Vaccine Market
9.4.5.2.1 Saudi Arabia Meningococcal Vaccine Market by Type
9.4.5.2.2 Saudi Arabia Meningococcal Vaccine Market by Brand
9.4.5.3 U.A.E Meningococcal Vaccine Market
9.4.5.3.1 U.A.E Meningococcal Vaccine Market by Type
9.4.5.3.2 U.A.E Meningococcal Vaccine Market by Brand
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Meningococcal Vaccine Market Overview
9.5.2 South and Central America Meningococcal Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Meningococcal Vaccine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Meningococcal Vaccine Market Forecasts and Analysis - By Brand
9.5.5 South and Central America Meningococcal Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Meningococcal Vaccine Market
9.5.5.1.1 Brazil Meningococcal Vaccine Market by Type
9.5.5.1.2 Brazil Meningococcal Vaccine Market by Brand
9.5.5.2 Argentina Meningococcal Vaccine Market
9.5.5.2.1 Argentina Meningococcal Vaccine Market by Type
9.5.5.2.2 Argentina Meningococcal Vaccine Market by Brand
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MENINGOCOCCAL VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MENINGOCOCCAL VACCINE MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SERUM INSTITUTE OF INDIA LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HUALAN BIOLOGICAL ENGINEERING INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INCEPTA PHARMACEUTICALS LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WALVAX BIOTECHNOLOGY CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-MANGUINHOS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. PFIZER INC
2. NOVARTIS AG
3. SANOFI
4. SERUM INSTITUTE OF INDIA LTD.
5. GLAXOSMITHKLINE PLC
6. MERCK AND CO., INC.
7. HUALAN BIOLOGICAL ENGINEERING INC.
8. INCEPTA PHARMACEUTICALS LTD
9. WALVAX BIOTECHNOLOGY CO., LTD.
10. BIO-MANGUINHOS
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For